The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
https://www.theguardian.com/world/live/2022/feb/02/covid-live-news-france-to-ease-some-restrictions-tsunami-hit-tonga-enters-lockdown
This should get good national press today
Might take a little while for the news to get out there... ORPH isn't quite the 'watched' stock it was a year ago.
The significance here is that ORPH is an ongoing Covid play - in addition to the core business.
Thanks moniman - it does look as if the stars are finally aligning...
Thanks for the feedback extrader, that is super interesting.
Morning Moni
I personally see this as a positive. It finally looks like Covid HTCs are going ahead. Offord might be running this one (with ORPH's challenge agent - and potentially trial and recruitment support too) but ORPH remains the only commercial option currently. There is going to be a lot of pharmas wanting to test products against covid... I'm hoping to see ORPH contract RNSs soon (soon being somewhat flexible, obviously ;-)
From memory, CF has said a few times that he is reluctant to RNS/announce the ethical approvals process.
Also, if i had to speculate, this is an Oxford/Welcome trial and ORPH is supplying the challenge agent (and possibly trial and recruitment support). So possibly no RNS for a bit, or at all.
The great news here is that a full Covid challenge trial has the go ahead (albeit with already infected and recovered subjects). I see this as huge news! It has been a long, long wait but it seems as though we'll finally get the Covid HCS.
https://twitter.com/UniofOxford/status/1486301105462071297?t=Yfx_13JwWozfDxa8WG7vYw&s=19
Fingers crossed
(hat tip: slim)
Quite Jimzi
And I think SENS serves as a good reposte to those who think institutional investors are a sign of stability, or a guarantee of success ;-)
Promoting a 'best in class' Covid test, in the same way he promoted a 'best in class' mask at RMS, is a lot harder if the serious phase of the pandemic is over.
Yes, the test has other uses... but they won't attract the same level of interest as a covid play.
I wonder if this selling is the start of a de-risking process...
"... surging cases of autoimmune diseases across the world meant new treatments and drugs were now urgently needed more than ever before"
https://www.theguardian.com/science/2022/jan/08/global-spread-of-autoimmune-disease-blamed-on-western-diet
Not new information - but more mainstream news awareness is always good
Hey Utah
"who would be selling?"
TBH, 16million shares traded isn't a huge amount. I'm not sure there were any MM shenanigans today...
It could be :
PIs selling some / all before any share consolidation vote (thinking they can buy back lower)
PIs thinking they can buy back in closer to the CTA and not wanting money tied up
Covid speculators deciding that the pandemic 'might' be easing off with Omicron and not up for the medium/long haul of clinical trials
Personally I'm just seeing this as a normal day on aim in the absence of news.
I think potnak is being realistic. From the final results (RNS)
"Exploratory Clinical Trial Application ("CTA") now expected to be filed mid-2022 owing to the additional time needed to manufacture capsule drug product, and subject to successful completion of final toxicity and safety studies"
The actual phase 1 trial might not start till the end of 2022 / start of 2023.
Also, the use of the word 'exploratory' is important. This usually indicates a very small scale trial prior to the main Phase 1 trial.
As I have suggested before... we are likely looking to Sierra for the first significant progress.
1. The UK tests considerably more than most European countries
2. Many more people are taking lateral flow tests before seeing friends and family over the holidays
3. There is a huge amount of covid cases currently
If anything, 180,000 is only part of the true number - especially as omicron is milder and many more will be asymptomatic and not testing. On the plus side, this should mean this wave is over soon...
Hey Caposoka
I welcome opposing views and considered criticism. I think most of the regular posters here do as well...
However, some of the posters that moniman has highlighted go way beyond this. In 18 months of LSE I have only filtered 5 users - and 3 of them are on moniman's list. They have consistently posted lies and misinformation and have done so multiple times over multiple threads (and sometimes even multiple boards).
Any legitimate points they make are lost in the continuous bile. Their agenda (and in one case, potential mental health issues) are obvious.
BeContrarian - great post :-)
As for myself - I'm calling it for the year and going to pour myself the first, of several, very large drinks.
Wishing you all a very happy, hopefully covid-free, Christmas - and a fabulous new year (and that includes all of you in the green filter bin too - no hard feeling and hope you have a great holiday season). Cheers, FTC
The purchase Breagh made has just been posted:
09:25:57 5.04 1,000,000 50.40k O
The other million looks like a sell
It's just the market today - nothing specific to Sareum. Think I'll turn off the laptop and head to the pub for a Christmas drink... before they all shut :-(
I doubt CF would have included anything requiring Government sign off in the pre Christmas news (twice bitten, third time definitely shy). We have had two cracking contract wins and positive AGS-v PLUS results. I'm taking that as the 3 pieces of news... There may well me something else (there is a lot going on behind the scenes I believe) but I'm not counting on anything else arriving this week.
A £5million+ contract, a £10million+ contract and the advancement of a universal mosquito borne disease vaccine is pretty stella to be fair :-)
Am I he only one seeing a negative here?
This is 40% discount on the previous placing.
The previous placings were for a premium above the current share price - this is below.
I'm not sure the market is going to see this as positively as some on this board...
Hey Moniman
That’s my thinking too. Looking at the buying pattern I suspect some positive news might be coming :-)